Ondansetron Injection
Product Images NDC 68083-113

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Ondansetron (NDC 68083-113). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Gland Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Ondansetron Spl Label

This is a description of Ondansetron Injection USP, manufactured by Gland Pharma Limited in Hyderabad, India. The injection contains 4mg of Ondansetron in 2mL of solution, with a concentration of 2 mg/mL. The product is intended for intravenous or intramuscular injection and is packaged with a barcode for identification. The expiration date of the product is included, but the lot number is not provided.*

FDA Label Image

Ondansetron Spl Structure

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.